Polaris, Shire stand to gain from potential $1.3B acquisition of Promedior
August 31, 2015 at 10:16 AM EDT
Boston venture capital firm Polaris Partners, Cambridge-based HealthCare Ventures and Lexington drug firm Shire Pharmaceuticals could all soon see a return on their investments in a 10-employee Lexington firm if a potential acquisition by Bristol-Myers Squibb for as much as $1...
